TWM579036U - Capsules - Google Patents

Capsules Download PDF

Info

Publication number
TWM579036U
TWM579036U TW107209143U TW107209143U TWM579036U TW M579036 U TWM579036 U TW M579036U TW 107209143 U TW107209143 U TW 107209143U TW 107209143 U TW107209143 U TW 107209143U TW M579036 U TWM579036 U TW M579036U
Authority
TW
Taiwan
Prior art keywords
sleeve
receiving
capsule
lutein
nattokinase
Prior art date
Application number
TW107209143U
Other languages
Chinese (zh)
Inventor
古榮海
古昕平
林慧儀
顧倖華
Original Assignee
蛋寶生技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 蛋寶生技股份有限公司 filed Critical 蛋寶生技股份有限公司
Priority to TW107209143U priority Critical patent/TWM579036U/en
Publication of TWM579036U publication Critical patent/TWM579036U/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

本新型提供一種膠囊,其係設有一膠囊本體以及一內含物,其中該膠囊本體具有一容置空間,該內含物係容置於該膠囊本體的容置空間內且包含複數個顆粒,該等顆粒係由蛋黃油、納豆激酶、葉黃素、星星果油及蛋白胜肽等原料所製成,藉以提供一種具有降低血管栓塞、改善視力的膠囊。 The present invention provides a capsule having a capsule body and an inclusion, wherein the capsule body has an accommodating space, and the content is contained in the accommodating space of the capsule body and includes a plurality of particles. The granules are made of raw materials such as egg butter, nattokinase, lutein, stark oil and protein peptide to provide a capsule having reduced blood vessel embolism and improved vision.

Description

膠囊 capsule

本新型係涉及一種膠囊,尤指一種具有降低血管栓塞、改善視力的膠囊。 The present invention relates to a capsule, and more particularly to a capsule having a reduced blood vessel embolism and improved vision.

現代人的生活充滿了來自各方的壓力,隨著年齡增長、工作及生活壓力都容易使現代人產生如用腦疲勞、高血壓引起的心血管疾病及視力減退等生理症狀,或是工作壓力所引起焦慮不安、難以專注及提不起勁的精神疲勞,長期過度疲勞下會對人體產生嚴重如血管栓塞及視力衰退等健康問題;經研究調查可得知,本國人健康最主要的問題來自於心血管疾病之血栓塞、肝病及眼睛黃斑部病變,因此,降低血管栓塞、改善視力是首要採取的措施之一。 The life of modern people is full of pressure from all parties. With age, work and life pressures, it is easy for modern people to develop physical symptoms such as brain fatigue, cardiovascular disease and vision loss caused by high blood pressure, or work stress. The mental fatigue caused by anxiety, difficulty, concentration and unsatisfaction, long-term excessive fatigue will cause serious health problems such as vascular embolism and vision loss. According to research and research, the most important problem of national health comes from Thrombosis, cardiovascular disease and macular degeneration of cardiovascular disease, therefore, reducing blood vessel embolism and improving vision is one of the first measures.

為了降低血管栓塞、改善視力,運動活絡血氣及戶外踏青是現代人經常採取的方法之一,實際現代人因為生活忙碌,難以規律運動,經常僅能偶爾運動一次,且單次長時間運動想彌補平常無法規律運動的時數,只是不規律運動或是單次長時間高強度運動,反而容易引起血栓瞬間引發從而發生心肌梗塞、腦血管梗塞等危急情形,而因工作長期使用電腦亦會讓視網膜栓塞造成血管破裂而引起瘀血,造成視力衰退;為了避免現代人因生活及工作壓力所造成的心血管疾病及視力衰退等健康問題,目前市面上多售有瓶裝降血壓及護眼產品,供疲勞的現代人飲用藉以改善身體機能,但,瓶裝產品體積過大,非合適隨身攜帶的能量補給品;另外,市面上含有降血壓及護眼產品等單一產品 多是要消費者分開食用,造成攜帶不便,綜上所述,現有降低血管栓塞、改善視力之方式及補給品誠有其需加以改進之處。 In order to reduce blood vessel embolism, improve vision, exercise, blood circulation and outdoor walking are one of the methods that modern people often take. Actually, modern people are busy with life, difficult to exercise regularly, often only occasionally exercise once, and a single long-term exercise wants to make up for normal The number of hours that can't be exercised regularly is just irregular movement or a single long-term high-intensity exercise. On the contrary, it is easy to cause a sudden onset of blood clots, resulting in a critical situation such as myocardial infarction and cerebral vascular infarction, and the long-term use of computers may cause retinal embolism. Blood vessels rupture and cause blood stasis, causing vision loss; in order to avoid health problems such as cardiovascular disease and vision loss caused by modern life and work stress, there are currently more bottles of blood pressure and eye protection products for fatigue. Modern people drink to improve their body functions. However, bottled products are too large and are not suitable for carrying energy supplements. In addition, the market has a single product such as blood pressure lowering and eye protection products. Mostly, it is necessary for consumers to eat separately, resulting in inconvenience in carrying. In summary, the existing methods of reducing blood vessel embolism, improving vision and supplies have some improvements.

為解決現有降低血管栓塞、改善視力之方式及補給品,無法配合現代人繁忙的生活模式,以及不方便攜帶的缺點,本新型的主要目的在於提供一種可解決目前技術問題的膠囊,其包括有:一膠囊本體,該膠囊本體具有一容置空間;以及一內含物,該內含物係容置於該膠囊本體的容置空間內且包含複數個顆粒,該等顆粒係由蛋黃油、納豆激酶、葉黃素、星星果油及蛋白胜肽等原料所製成。 In order to solve the existing methods of reducing blood vessel embolism, improving vision and supplements, unable to cope with the busy lifestyle of modern people, and the disadvantages of being inconvenient to carry, the main purpose of the present invention is to provide a capsule that can solve the current technical problems, including a capsule body having an accommodating space; and an inclusion contained in the accommodating space of the capsule body and containing a plurality of granules, the granules being composed of egg butter, It is made from raw materials such as nattokinase, lutein, star fruit oil and protein peptide.

進一步,如前所述之膠囊,其中該膠囊本體係包括一容設筒及一結合套,其中該容設筒係為一內部呈空心狀之橢圓殼體,該結合套係為一內部呈空心狀之橢圓殼體,且該結合套之內徑與該容設筒之外徑相對應,使該結合套能拆卸地套合於該容設筒外而組成該膠囊本體,所述的容置空間係形成於該容設筒與該結合套之間。 Further, the capsule as described above, wherein the capsule system comprises a receiving sleeve and a joint sleeve, wherein the receiving cylinder is an elliptical shell having a hollow interior, the joint sleeve being hollow inside. An elliptical housing, and an inner diameter of the coupling sleeve corresponds to an outer diameter of the receiving sleeve, so that the coupling sleeve is detachably fitted outside the receiving sleeve to form the capsule body, and the receiving body is formed A space system is formed between the receiving tube and the coupling sleeve.

再進一步,如前所述之膠囊,其中該容設筒之外表面設有至少一凹部,該結合套於鄰近其開口的內表面處設有至少一凸部,且該至少一凸部與該容設筒之至少一凹部相對應,使該結合套套合於該容設筒外時,該至少一凸部能與該至少一凹部相嵌合,藉以增加該容設筒及該結合套相套合時之緊密度。 Further, in the capsule as described above, the outer surface of the receiving sleeve is provided with at least one concave portion, and the coupling sleeve is provided with at least one convex portion at an inner surface adjacent to the opening thereof, and the at least one convex portion is The at least one convex portion is engageable with the at least one concave portion when the coupling sleeve is fitted to the outside of the receiving sleeve, so as to increase the receiving sleeve and the combined sleeve Closeness of time.

藉由上述的技術手段,由於該內含物係由蛋黃油、納豆激酶、葉黃素、星星果油及蛋白胜肽等原料所製成的複數個顆粒,其中該蛋黃油、該星星果油、及該葉黃素三者為協同效果,有效促進該葉黃素吸收,提升該葉黃素的生物利用率,順利將該葉黃素傳送到眼睛的黃斑部,實質保護眼睛之視網 膜細胞,進而達到改善視力之效果,而該納豆激酶及該蛋白胜肽能降低血管栓塞及恢復體力,該納豆激酶具有與人體製造纖溶酵素可溶解血栓之能力,亦可活化製造纖溶酵素的前驅物,可有效改善血壓及預防血栓症,經研究證實,高血壓受試者食用含有該納豆激酶成分之膠囊,於食用後第二週已經有效改善血液循環,於食用後第六週已經有效降低血壓,故該納豆激酶能夠有效降低高血壓患者之血壓、提高血流並改善血液循環,進而達到降低血管栓塞之功效;每日食用兩粒本新型的膠囊,即可有效降低血管栓塞、改善視力,相對市售含有降血壓及護眼產品一般多是要消費者分開食用,造成攜帶不便,本新型具有方便攜帶、能及時補充且更加經濟實惠等優點。 According to the above technical means, the inclusion is a plurality of particles made of raw materials such as egg butter, nattokinase, lutein, star fruit oil and protein peptide, wherein the egg butter and the star fruit oil And the lutein three synergistic effects, effectively promoting the lutein absorption, improving the bioavailability of the lutein, smoothly transferring the lutein to the macula of the eye, and substantially protecting the eye. Membrane cells, which further improve the visual acuity, and the nattokinase and the peptide peptide can reduce blood vessel embolism and restore physical strength. The nattokinase has the ability to dissolve thrombus with human body to produce fibrinolytic enzyme, and can also activate the production of fibrinolytic enzyme. The precursor can effectively improve blood pressure and prevent thrombosis. It has been confirmed by research that hypertensive subjects consume capsules containing the nattokinase component, which has effectively improved blood circulation in the second week after consumption. Effectively lowering blood pressure, the nattokinase can effectively reduce the blood pressure of patients with hypertension, improve blood flow and improve blood circulation, thereby reducing the effect of vascular embolization; daily consumption of two capsules of the new type can effectively reduce blood vessel embolism, To improve vision, compared with commercially available products that contain blood pressure lowering and eye protection products, consumers are generally required to eat separately, resulting in inconvenience of carrying. The new type has the advantages of being convenient to carry, being able to be replenished in time, and being more economical.

10‧‧‧膠囊本體 10‧‧‧Capsule body

10A‧‧‧膠囊本體 10A‧‧‧Capsule body

11‧‧‧容設筒 11‧‧‧Capacity

11A‧‧‧容設筒 11A‧‧‧Capacity

111A‧‧‧凹部 111A‧‧‧ recess

12‧‧‧結合套 12‧‧‧ combined sets

12A‧‧‧結合套 12A‧‧‧ combined set

121A‧‧‧凸部 121A‧‧‧ convex

13‧‧‧容置空間 13‧‧‧ accommodating space

20‧‧‧內含物 20‧‧‧ inclusions

30‧‧‧蛋黃油 30‧‧‧ Egg Butter

40‧‧‧納豆激酶 40‧‧‧Nattokinase

50‧‧‧葉黃素 50‧‧‧ lutein

60‧‧‧星星果油 60‧‧‧Star Oil

70‧‧‧蛋白胜肽 70‧‧‧ protein peptide

圖1係本新型之第一較佳實施例之立體外觀圖。 1 is a perspective view of a first preferred embodiment of the present invention.

圖2係本新型之第一較佳實施例之組合方式示意圖。 2 is a schematic view showing the combination of the first preferred embodiment of the present invention.

圖3係本新型之第一較佳實施例之局部剖面側視圖。 Figure 3 is a partial cross-sectional side view of the first preferred embodiment of the present invention.

圖4係本新型之第一較佳實施例之內含物的原料成分組成示意圖。 Fig. 4 is a schematic view showing the composition of raw materials of the contents of the first preferred embodiment of the present invention.

圖5係本新型之第二較佳實施例之局部剖面側視圖。 Figure 5 is a partial cross-sectional side view of a second preferred embodiment of the present invention.

圖6係本新型之第一較佳實施例之使用狀態示意圖。 Figure 6 is a schematic view showing the state of use of the first preferred embodiment of the present invention.

為能詳細瞭解本新型的技術特徵及實用功效,並可依照說明書的內容來實現,茲進一步以如圖式所示的較佳實施例,詳細說明如後:本新型所提出的膠囊之第一較佳實施例如圖1至3所示,其係包括一膠囊本體10及一內含物20,其中:該膠囊本體10係包括一容設筒11、一結合套12及一容置空間13,其中該容設筒11係為一內部呈空心狀之橢圓殼體,該結合套12係為一內部 呈空心狀之橢圓殼體,且該結合套12之內徑與該容設筒11之外徑相對應,使該結合套12能拆卸地套合於該容設筒11外而組成該膠囊本體10,該容置空間13設置於該容設筒11與該結合套12之間。 In order to understand the technical features and practical effects of the present invention in detail, and in accordance with the contents of the specification, the present invention will be further described in detail with reference to the preferred embodiments as illustrated in the following: The preferred embodiment is shown in FIG. 1 to FIG. 3 , which includes a capsule body 10 and an inclusion 20 , wherein the capsule body 10 includes a receiving sleeve 11 , a coupling sleeve 12 and an accommodating space 13 . The receiving sleeve 11 is an elliptical housing having a hollow interior, and the coupling sleeve 12 is an internal part. An elliptical shell having a hollow shape, and an inner diameter of the sleeve 12 corresponding to an outer diameter of the receiving sleeve 11 to detachably fit the sleeve 12 outside the receiving sleeve 11 to form the capsule body The accommodating space 13 is disposed between the accommodating cylinder 11 and the coupling sleeve 12 .

該內含物20係容置於該膠囊本體10的容置空間13中,請配合參看如圖4所示,該內含物20係由蛋黃油30、納豆激酶40、葉黃素50、星星果油60及蛋白胜肽70等原料所製成的複數個顆粒,其中該蛋黃油30含磷脂與DHA,經低溫低壓製成,該蛋黃油30具有多種人體保養功能,包含活化視網膜及視神經影像傳輸能力之眼睛保養、增加血管擴張及改善血管括約肌之穩定血壓、抗心律不整、增加高密度血脂及減少動脈硬化功能,讓食用者能有效降低血管栓塞。 The inclusions 20 are accommodated in the accommodating space 13 of the capsule body 10. Referring to FIG. 4, the inclusion 20 is composed of egg butter 30, nattokinase 40, lutein 50, and stars. a plurality of particles made of raw materials such as fruit oil 60 and protein peptide 70, wherein the egg butter 30 contains phospholipids and DHA, and is prepared by low temperature and low pressure. The egg butter 30 has various human body maintenance functions, including activated retina and optic nerve images. Eye maintenance of transmission capacity, increased vasodilation and improved stable blood pressure of the sphincter, anti-arrhythmia, increased high-density blood lipids and reduced arteriosclerosis, so that consumers can effectively reduce blood vessel embolism.

該納豆激酶40能直接分解血栓,故具有與人體中的纖溶酵素(Plasmin)能溶解血栓相同的能力,且該納豆激酶40亦可活化製造纖溶酵素的前驅物,故能有效改善血壓,經研究證實,高血壓受試者食用含有該納豆激酶40成分之膠囊,於食用後第二週已經有效改善血液循環,於食用後第六週已經有效降低血壓,故該納豆激酶40能夠有效降低高血壓患者之血壓、提高血流並改善血液循環,進而達到降低血管栓塞之功效。 The nattokinase 40 can directly decompose the thrombus, so it has the same ability to dissolve thrombus in the human body, and the nattokinase 40 can also activate the precursor of the production of fibrinolytic enzyme, thereby effectively improving blood pressure. Studies have confirmed that hypertensive subjects consume capsules containing the nattokinase 40 component, which has effectively improved blood circulation in the second week after consumption, and has effectively reduced blood pressure in the sixth week after consumption, so the nattokinase 40 can effectively reduce The blood pressure of patients with hypertension, improve blood flow and improve blood circulation, thereby achieving the effect of reducing blood vessel embolism.

該葉黃素50係金盞花萃取物,其係包括葉黃素酯及玉米黃素酯等天然成分,該葉黃素50係為酯化型葉黃素,經研究實驗顯示,游離型葉黃素在胃酸環境下容易降解,酯化型葉黃素則可相對完整到達小腸,充分被人體吸收利用,於工作長期使用電腦族群,建議補充額外的該葉黃素50,藉以改善因用眼過度而造成視力衰退之現象,以避免眼睛黃斑部病變,進而能保養並修復視網膜。 The lutein 50 is a calendula extract, which comprises a natural component such as lutein ester and zeaxanthin, and the lutein 50 is an esterified lutein, and the research shows that the free lutein It is easily degraded in the stomach acid environment, and the esterified lutein can reach the small intestine relatively completely, and is fully absorbed and utilized by the human body. It is recommended to supplement the lutein 50 for a long time in the work, so as to improve the use of the eye. Causes vision loss to avoid macular degeneration in the eye, which in turn can maintain and repair the retina.

該星星果油60經低溫冷壓初榨製成,且該星星果油60之Omega-3脂肪酸含量達40%以上,該星星果油60具有護眼功能,可使視網膜細胞柔軟, 進而刺激感光細胞,提升視覺功效,降低老年性黃斑部病變的發生率,保護視網膜神經細胞,改善眼睛乾澀,增加血管通透性及彈性,提高眼睛對營養素的利用;也具有強心功能,可降低心血管疾病發生率,降低血壓及血中膽固醇,減少炎症發生及血栓形成;該星星果油60及該蛋黃油30有助眼睛視網膜對該葉黃素50的吸收,由實驗研究證實,身體吸收的葉黃素越多,所達的生物利用率越高,能順利將葉黃素傳送到眼睛的黃斑部,可有效改善視力狀況。 The star fruit oil 60 is produced by low-temperature cold pressing and virgin, and the star fruit oil 60 has an Omega-3 fatty acid content of more than 40%. The star fruit oil 60 has an eye-protecting function and can make the retinal cells soft. In turn, it stimulates photoreceptor cells, enhances visual effects, reduces the incidence of age-related macular degeneration, protects retinal nerve cells, improves dry eyes, increases vascular permeability and elasticity, improves eye utilization of nutrients, and has cardiac function, which can reduce The incidence of cardiovascular disease, lower blood pressure and blood cholesterol, reduce inflammation and thrombosis; the star fruit oil 60 and the egg butter 30 help the eye retina to absorb lutein 50, confirmed by experimental research, body absorption The more lutein, the higher the bioavailability, and the smooth delivery of lutein to the macula of the eye, which can effectively improve vision.

同時,該蛋白胜肽70是小分子雞蛋蛋白胜肽,該蛋白胜肽70透過高效液相層析法(HPLC),測得其相對分子量在1000Dal以下的比率佔80%以上,故稱為小分子胜肽;該蛋白胜肽70具有多種特性及功能,如凝膠性、乳化性、起泡性、親水性和熱凝結性等;該蛋白胜肽70具有補充蛋白質營養和必需胺基酸的作用外,對人體還具備許多調節功能,如調節免疫、促進食物中各種營養物質在腸道的吸收等多種生理調節功能,該蛋白胜肽70是小分子雞蛋蛋白胜肽,更有利於人體吸收率,適合做為提升免疫力、降低心血管疾病及疲勞修復等功能。 Meanwhile, the protein peptide 70 is a small molecule egg protein peptide, and the peptide peptide 70 is subjected to high performance liquid chromatography (HPLC), and the ratio of the relative molecular weight below 1000 Dal is more than 80%, so it is called small. Molecular peptide; the peptide peptide 70 has various properties and functions such as gelation, emulsifying property, foaming property, hydrophilicity and thermal coagulation property; the peptide peptide 70 has protein nutrition supplement and essential amino acid In addition to the role, the human body also has many regulatory functions, such as regulating immunity, promoting the absorption of various nutrients in the food and other physiological regulation functions. The peptide peptide 70 is a small molecule egg protein peptide, which is more beneficial to human body absorption. Rate, suitable for improving immunity, reducing cardiovascular disease and fatigue repair.

本新型所提出的膠囊的第二較佳實施例如圖5所示,該第二較佳實施例之構造大致與第一較佳實施例相同,不同之處在於:該容設筒11A之外表面設有至少一凹部111A,該結合套12A於鄰近其開口的內表面處設有至少一凸部121A,且該至少一凸部121A與該容設筒11A之至少一凹部111A相對應,使該結合套12A套合於該容設筒11A外時,該至少一凸部121A能與該至少一凹部111A相嵌合,藉以增加該容設筒11A及該結合套12A相套合時之緊密度,使該膠囊本體10A的該容設筒11A及該結合套12A相對不易分開。 A second preferred embodiment of the presently proposed capsule is shown in FIG. 5. The configuration of the second preferred embodiment is substantially the same as that of the first preferred embodiment, except that the outer surface of the receiving cylinder 11A is At least one concave portion 111A is disposed, and the coupling sleeve 12A is provided with at least one convex portion 121A adjacent to the inner surface of the opening thereof, and the at least one convex portion 121A corresponds to at least one concave portion 111A of the receiving cylinder 11A, so that the When the sleeve 12A is sleeved outside the receiving sleeve 11A, the at least one convex portion 121A can be engaged with the at least one concave portion 111A, thereby increasing the tightness of the receiving sleeve 11A and the joint sleeve 12A when the sleeve is assembled. The receiving tube 11A of the capsule body 10A and the coupling sleeve 12A are relatively difficult to separate.

綜上所述,該蛋黃油30、該星星果油60、及該葉黃素50三者協同作用,改善眼睛疲勞,有效降低眼球黃斑部病變發生率,保護眼睛視網膜細胞;而該納豆激酶40及該蛋白胜肽70能降低血管栓塞及恢復體力,該納豆激酶 40具有與人體製造纖溶酵素可溶解血栓之能力,亦可活化製造纖溶酵素的前驅物,可有效改善血壓及預防血栓症,是人體血管的清道夫,長期使用電腦工作者,可有效改善眼動脈栓塞症,改善患者視力,促進增加眼部血流量,幫助栓塞溶解,讓瘀血消失,有效降低血管栓塞;由於本新型的膠囊中的內含物20係由該蛋黃油30、該納豆激酶40、該葉黃素50、該星星果油60及該蛋白胜肽70等原料所製成的複數個顆粒,故食用該膠囊後,請配合參看如圖6所示,能讓食用者降低血管栓塞、改善視力,維持最佳身體狀態。 In summary, the egg butter 30, the star fruit oil 60, and the lutein 50 synergistically improve eye fatigue, effectively reduce the incidence of macular degeneration in the eye, and protect the retinal cells of the eye; and the nattokinase 40 And the protein peptide 70 can reduce blood vessel embolism and restore physical strength, the nattokinase 40 has the ability to dissolve fibrinolytic enzymes with human body, and can also activate precursors for the production of fibrinolytic enzymes, which can effectively improve blood pressure and prevent thrombosis. It is a scavenger of human blood vessels, and can be effectively improved by long-term use of computer workers. Ophthalmic embolism, improve the patient's vision, promote the increase of ocular blood flow, help embolization, let blood stasis disappear, effectively reduce blood vessel embolism; because the content of the capsule in this new type 20 is from the egg butter 30, the natto a plurality of particles made of a raw material such as the kinase 40, the lutein 50, the star fruit oil 60, and the protein peptide 70, so after eating the capsule, please refer to FIG. 6 for the consumer to lower. Vascular embolization, improved vision, and optimal body condition.

每日食用兩粒本新型的膠囊,即可有效改善血壓、預防血栓症、保養眼睛及預防黃斑部病變,相對市售含有降血壓及護眼產品一般多是要消費者分開食用,造成攜帶不便,增有方便攜帶、能及時補充且更加經濟實惠等優點;本新型的膠囊,適合勞心勞力壓力上班族、長期用眼過度之電腦族、高血壓者、睡眠不足及作息不正常者。 Eat two capsules of this new type daily, which can effectively improve blood pressure, prevent thrombosis, maintain eyes and prevent macular degeneration. Compared with commercially available products that contain blood pressure lowering and eye care products, consumers are usually eaten separately, resulting in inconvenience of carrying. The utility model has the advantages of being convenient to carry, being able to be replenished in time and being more economical and the like; the capsule of the novel is suitable for laboring labor stress workers, computer users with long-term use of excessive eyes, high blood pressure, lack of sleep and abnormal work and rest.

Claims (3)

一種膠囊,其係設有:一膠囊本體,該膠囊本體具有一容置空間;以及一內含物,該內含物係容置於該膠囊本體的容置空間內且包含複數個顆粒,該等顆粒係由蛋黃油、納豆激酶、葉黃素、星星果油及蛋白胜肽等原料所製成。 The capsule is provided with a capsule body having an accommodating space, and an inclusion contained in the accommodating space of the capsule body and containing a plurality of particles. The granules are made of raw materials such as egg butter, nattokinase, lutein, star fruit oil and protein peptide. 如請求項1所述之膠囊,其中該膠囊本體係包括一容設筒及一結合套,其中該容設筒係為一內部呈空心狀之橢圓殼體,該結合套係為一內部呈空心狀之橢圓殼體,且該結合套之內徑與該容設筒之外徑相對應,使該結合套能拆卸地套合於該容設筒外而組成該膠囊本體,所述的容置空間係形成於該容設筒與該結合套之間。 The capsule according to claim 1, wherein the capsule system comprises a receiving sleeve and a joint sleeve, wherein the receiving cylinder is an elliptical shell having a hollow interior, the joint sleeve being hollow inside. An elliptical housing, and an inner diameter of the coupling sleeve corresponds to an outer diameter of the receiving sleeve, so that the coupling sleeve is detachably fitted outside the receiving sleeve to form the capsule body, and the receiving body is formed A space system is formed between the receiving tube and the coupling sleeve. 如請求項2所述之膠囊,其中該容設筒之外表面設有至少一凹部,該結合套於鄰近其開口的內表面處設有至少一凸部,且該至少一凸部與該容設筒之至少一凹部相對應,使該結合套套合於該容設筒外時,該至少一凸部能與該至少一凹部相嵌合,藉以增加該容設筒及該結合套相套合時之緊密度。 The capsule according to claim 2, wherein the outer surface of the receiving sleeve is provided with at least one concave portion, and the binding sleeve is provided with at least one convex portion at an inner surface adjacent to the opening thereof, and the at least one convex portion and the receiving portion The at least one convex portion is engageable with the at least one concave portion when the coupling sleeve is sleeved on the outer side of the receiving sleeve, so as to increase the receiving sleeve and the combined sleeve The tightness of time.
TW107209143U 2018-07-06 2018-07-06 Capsules TWM579036U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW107209143U TWM579036U (en) 2018-07-06 2018-07-06 Capsules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW107209143U TWM579036U (en) 2018-07-06 2018-07-06 Capsules

Publications (1)

Publication Number Publication Date
TWM579036U true TWM579036U (en) 2019-06-11

Family

ID=67703875

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107209143U TWM579036U (en) 2018-07-06 2018-07-06 Capsules

Country Status (1)

Country Link
TW (1) TWM579036U (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113466289A (en) * 2021-06-28 2021-10-01 中国农业大学 System and method for measuring vulnerability of crop leaf embolism
CN114099975A (en) * 2021-11-15 2022-03-01 北京京东方技术开发有限公司 Stomach retention capsule, waistband and method for stimulating stomach nerves

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113466289A (en) * 2021-06-28 2021-10-01 中国农业大学 System and method for measuring vulnerability of crop leaf embolism
CN114099975A (en) * 2021-11-15 2022-03-01 北京京东方技术开发有限公司 Stomach retention capsule, waistband and method for stimulating stomach nerves
CN114099975B (en) * 2021-11-15 2023-07-14 北京京东方技术开发有限公司 Gastric retention capsule, waistband and gastric nerve stimulation method

Similar Documents

Publication Publication Date Title
Riva et al. The effect of a natural, standardized bilberry extract (Mirtoselect®) in dry eye: a randomized, double blinded, placebo-controlled trial.
CN103735733B (en) A kind of compound preparation containing lutein ester and preparation method thereof
CN107048122A (en) A kind of hoveniae semoveniae semen health drink of energy relieving alcoholism and protecting liver and preparation method thereof
CN102742656B (en) Milky tea relieving asthenopia and preparation method thereof
CN101926483A (en) Medlar and chrysanthemum eyesight-improving intelligence-developing health care drink
JP2008271878A (en) Novel food and drink
TWM579036U (en) Capsules
CN101816355A (en) Anti-fatigue alternative tea and preparation method thereof
CN104997015A (en) Composition capable of regulating blood stasis constitutions and preparation method of composition
CN105341946A (en) Dunaliella salina, lutein and huckleberry composition, soft capsule containing composition and preparation method of soft capsule
CN108041609B (en) Food composition with functions of relieving visual fatigue and preventing myopia and preparation method thereof
CN102550770A (en) Mountain daisy coffee drink
CN105767313A (en) Healthcare ground tea with refreshing and intelligence enhancing functions and preparing method
CN103637313A (en) Fruit and vegetable beverage for preventing neurasthenia and preparation process thereof
CN101085149A (en) Porridge containing Chinese yam and almond
CN105901577A (en) Nutritional agent for reinforcing brain, protecting eye and strengthening body and preparation method and application thereof
CN112385755A (en) A preparation method of fruit and vegetable beverage with eyesight protecting effect
JP2013010714A (en) Eye fatigue suppressing composition and food and drink including the same
CN104000182A (en) Nutritional fruit congee for pregnant woman and lying-in woman
Eftekhari et al. Non-pharmacological management (hydration, diet and compression)
CN106689991A (en) Combination formula of fructus lycii porridge
CN110507770A (en) Alternative tea drops clearly in a kind of double leaf heart of a lotus seed jujube
CN106615408A (en) Health tea
CN112042939A (en) A supplementary retinal nutrition chewable tablet
CN110403125A (en) A kind of antihypelipidemic foodstuff compositions, process